-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qz0kcNwEyhMUHIkMOy7oUPJaGZw8rnQzhB0NQPvFbyvWnnigEpKZL0Kr4BbmIQvU JOhqSKU+p2SSrnYG+dNsGg== 0001181431-06-004148.txt : 20060118 0001181431-06-004148.hdr.sgml : 20060118 20060118213212 ACCESSION NUMBER: 0001181431-06-004148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060118 FILED AS OF DATE: 20060118 DATE AS OF CHANGE: 20060118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feldman Thomas CENTRAL INDEX KEY: 0001293632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50794 FILM NUMBER: 06536690 BUSINESS ADDRESS: BUSINESS PHONE: (650) 808-6500 MAIL ADDRESS: STREET 1: 5000 SHORELINE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COTHERIX INC CENTRAL INDEX KEY: 0001138812 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043513144 BUSINESS ADDRESS: STREET 1: 5000 SHORELINE COURT STREET 2: SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-808-6500 MAIL ADDRESS: STREET 1: 5000 SHORELINE COURT STREET 2: SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXHALE THERAPEUTICS INC DATE OF NAME CHANGE: 20010503 4 1 rrd104045.xml 1/18/06 OPTION EXERCISE X0202 4 2006-01-18 0 0001138812 COTHERIX INC CTRX 0001293632 Feldman Thomas 5000 SHORELINE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Business Officer Common Stock 2006-01-18 4 M 0 75000 0.5446 A 125000 D Stock Option (Right to Buy) 0.5446 2006-01-18 4 M 0 75000 0 D 2014-01-08 Common Stock 75000 97720 D The option grant was exercisable on January 9, 2004, the date of grant. Vesting of the option grant commenced on December 16, 2004, at which time 25% of the shares vested. The remainder of the shares began vesting in 36 equal monthly installments from December 16, 2004. As of January 18, 2006, 66,000 of the shares exercised had vested. The 9,000 unvested shares exercised remain subject to a repurchase right that will lapse as the shares vest. /s/ Thomas Feldman 2006-01-18 -----END PRIVACY-ENHANCED MESSAGE-----